Stock market week-in-review for 5 large GI companies — Sept. 18-22

Written by Eric Oliver | September 26, 2017 | Print  |

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 18 to Sept. 22, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $220.24 on Sept. 18
Peaked: $227.36 on Sept. 18
Closed: $204.61 on Sept. 22
Percent change between Sept. 18 and Sept. 22: -7.09 percent

2. Exact Sciences Corp.

Opened: $42.75 on Sept. 18
Peaked: $46.09 on Sept. 22
Closed: $45.90 on Sept. 22
Percent change between Sept. 18 and Sept. 22: 7.36 percent

3. Johnson & Johnson

Opened: $134.54 on Sept. 18
Peaked: $136.65 on Sept. 18
Closed: $ 131.36 on Sept. 22
Percent change between Sept. 18 and Sept. 22: -2.36 percent

4. Synergy Pharmaceuticals

Opened: $2.72 on Sept. 18
Peaked: $2.79 on Sept. 18
Closed: $2.59 on Sept. 22
Percent change between Sept. 18 and Sept. 22: -4.77 percent

5. Valeant Pharmaceuticals

Opened: $13.93 on Sept. 18
Peaked: $14.37 on Sept. 21
Closed: $14.03 on Sept. 22
Percent change between Sept. 18 and Sept. 22: 0.71 percent

More articles on gastroenterology: 
GI leader to know: Dr. Daryl M. McClendon of Alaska Digestive and Liver Disease Clinic
12 statistics on gastroenterologist salary — $357k is median
Penn State College of Medicine taps Dr. Thomas Ma for chairmanship — 4 key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.